BridgeBio

Eli Wallace, Ph.D. is the Chief Scientific Officer of Oncology at BridgeBio. Previously, he held senior roles at Peloton Therapeutics, where he was the Chief Scientific Officer, and Array BioPharma. Dr. Wallace has co-authored 25 original research articles and invited reviews and is co-inventor on 79-issued U.S. patents.

He received his B.S. from Northwestern University and his Ph.D. from Colorado State University.

Sr. Manager/associate Director, Quality Assurance

Sr. IT Infrastructure Engineer

Sr. Executive Assistant, Business Development & Operations

Sr. Director, Regulatory Operations, Business Systems

Sr. Clinical Data Manager

Sr. Animal Technician

Regional Medical Director

Quality Assurance Manager, EU

Medical Director, Clinical Development

Manager, Quality Control

Manager, Community & Communications

International Director, Marketing

Head Of Credit Risk Compliance

Director, Program Management

Director, Medical Writing

Director, Medical Affairs

Director, Marketing Excellence

Clinical Scientist/associate Medical Director, Clinical Development

Associate Director/director, Biostatistics

Accounting Manager, R&d

Manager/sr. Manager, Sales Operations

Director/sr. Director, Value & Health Economics

Associate Director, Analytical Chemistry

Eli Wallace

Chief Scientific Officer, Oncology at BridgeBio

Org chart

Manager

Peers

Reports

Timeline

Chief Scientific Officer, Oncology